Evaluation of Surface Acoustics Ultrasound Device for the Treatment of Patients With Percutaneous Nephrostomy Catheters
Launched by ASSAF-HAROFEH MEDICAL CENTER · Jun 19, 2008
Trial Information
Current as of April 28, 2025
Unknown status
Keywords
ClinConnect Summary
The UroShield™ System is comprised of 2 main components:· The Disposable UroShield Z-Patch - a disposable small lightweight patch that is attached to the PCN catheter, while its opposite side is attached directly to the patient's skin at the site of catheter entry. The patch has twofold function:
1. it receives energy and a signal from the UroShield Driver allowing it to generate the ultrasonic waves;
2. it acts as a fixation device for the PCN catheter.· The UroShield Driver - an external driver unit that is attached to the UroShield patch and contains batteries to power the system and el...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients requiring percoutaneous nephrostome
- • First insertion
- Exclusion Criteria:
- • Blood coagulation disorders
- • Trauma
About Assaf Harofeh Medical Center
Assaf-Harofeh Medical Center is a prominent healthcare institution located in Israel, renowned for its commitment to advancing medical research and improving patient care. As a key sponsor of clinical trials, the center focuses on a diverse range of therapeutic areas, leveraging its state-of-the-art facilities and interdisciplinary expertise to facilitate innovative studies. With a dedicated team of experienced researchers and clinicians, Assaf-Harofeh Medical Center is dedicated to fostering scientific breakthroughs that enhance treatment outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zerifin, Isarel, Israel
Patients applied
Trial Officials
Yoram I Siegel, MD
Principal Investigator
Assaf Harofeh MC
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials